東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Retinal degeneration- Treatment." ]

切換: 標籤 | MARC模式 | ISBD

Cell-based therapy for degenerative ...

Zarbin, Marco A.

FindBook

Google Book

Amazon

博客來

Cell-based therapy for degenerative retinal disease

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cell-based therapy for degenerative retinal disease/ edited by Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano.
其他作者:	Zarbin, Marco A.
出版者:	Cham :Springer International Publishing : : 2019.,
面頁冊數:	xi, 280 p. :ill. (some col.), digital ;24 cm.
內容註:	Advantages of the Eye as a Target Organ for Cell-Based Therapy in the Central Nervous System -- Proof of Principle: Preclinical Data on Retinal Cell Transplantation -- Clinical and Pathological Features of Selected Human Retinal Degenerative Diseases -- Degenerative Retinal Diseases: Cells sources for cell-based therapy -- Manufacturing of Clinical Grade Cellular Products Under Gmp Conditions -- Regulatory Requirements for Cell-Based Therapy for Degenerative Retinal Disease -- Biomaterials and Scaffolds for Cell Replacement Therapy -- Restoration of cone photoreceptor function in retinitis pigmentosa (RP) - retinal cell-based therapy -- Cell Delivery: Surgical Approaches -- Diagnosis and Complementary Examinations -- Cell Therapy for Degenerative Retinal Disease: special focus on cell fusion-mediated regeneration -- Clinical Trials of Retinal Cell Therapy -- Future Directions -- Index.
Contained By:	Springer eBooks
標題:	Retinal degeneration - Treatment. -
電子資源:	https://doi.org/10.1007/978-3-030-05222-5
ISBN:	9783030052225

Cell-based therapy for degenerative retinal disease
Cell-based therapy for degenerative retinal disease[electronic resource] /edited by Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano. - Cham :Springer International Publishing :2019. - xi, 280 p. :ill. (some col.), digital ;24 cm. - Stem cell biology and regenerative medicine,2196-8985. - Stem cell biology and regenerative medicine..

Advantages of the Eye as a Target Organ for Cell-Based Therapy in the Central Nervous System -- Proof of Principle: Preclinical Data on Retinal Cell Transplantation -- Clinical and Pathological Features of Selected Human Retinal Degenerative Diseases -- Degenerative Retinal Diseases: Cells sources for cell-based therapy -- Manufacturing of Clinical Grade Cellular Products Under Gmp Conditions -- Regulatory Requirements for Cell-Based Therapy for Degenerative Retinal Disease -- Biomaterials and Scaffolds for Cell Replacement Therapy -- Restoration of cone photoreceptor function in retinitis pigmentosa (RP) - retinal cell-based therapy -- Cell Delivery: Surgical Approaches -- Diagnosis and Complementary Examinations -- Cell Therapy for Degenerative Retinal Disease: special focus on cell fusion-mediated regeneration -- Clinical Trials of Retinal Cell Therapy -- Future Directions -- Index.

This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of "de-risking" that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology.

ISBN: 9783030052225

Standard No.: 10.1007/978-3-030-05222-5doiSubjects--Topical Terms:

2152737
Retinal degeneration
--Treatment.

LC Class. No.: RE661.D3 / C455 2019

Dewey Class. No.: 617.735

Cell-based therapy for degenerative retinal disease
LDR:02752nmm a2200337 a 4500 001 2179689
003 DE-He213
005 20190827114641.0
006 m d
007 cr nn 008maaau
008 191122s2019 gw s 0 eng d
020 $a 9783030052225 $q (electronic bk.)
020 $a 9783030052218 $q (paper)
024 7 $a 10.1007/978-3-030-05222-5 $2 doi
035 $a 978-3-030-05222-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RE661.D3 $b C455 2019
072 7 $a PSAK $2 bicssc
072 7 $a SCI017000 $2 bisacsh
072 7 $a PSAK $2 thema
082 0 4 $a 617.735 $2 23
090 $a RE661.D3 $b C393 2019
245 0 0 $a Cell-based therapy for degenerative retinal disease $h [electronic resource] / $c edited by Marco A. Zarbin, Mandeep S. Singh, Ricardo P. Casaroli-Marano.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2019.
300 $a xi, 280 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Stem cell biology and regenerative medicine, $x 2196-8985
505 0 $a Advantages of the Eye as a Target Organ for Cell-Based Therapy in the Central Nervous System -- Proof of Principle: Preclinical Data on Retinal Cell Transplantation -- Clinical and Pathological Features of Selected Human Retinal Degenerative Diseases -- Degenerative Retinal Diseases: Cells sources for cell-based therapy -- Manufacturing of Clinical Grade Cellular Products Under Gmp Conditions -- Regulatory Requirements for Cell-Based Therapy for Degenerative Retinal Disease -- Biomaterials and Scaffolds for Cell Replacement Therapy -- Restoration of cone photoreceptor function in retinitis pigmentosa (RP) - retinal cell-based therapy -- Cell Delivery: Surgical Approaches -- Diagnosis and Complementary Examinations -- Cell Therapy for Degenerative Retinal Disease: special focus on cell fusion-mediated regeneration -- Clinical Trials of Retinal Cell Therapy -- Future Directions -- Index.
520 $a This book discusses why specific diseases are being targeted for cell-based retinal therapy, what evidence exists that justifies optimism for this approach, and what challenges must be managed in order to bring this technology from the laboratory into routine clinical practice. There are a number of unanswered questions (e.g., surgical approach to cell delivery, management of immune response, optimum cell type to transplant) that very likely are not going to be answered until human trials are undertaken, but there is a certain amount of "de-risking" that can be done with preclinical experimentation. This book is essential reading for scientists, clinicians, and advanced students in stem cell research, cell biology, and ophthalmology.
650 0 $a Retinal degeneration $x Treatment. $3 2152737
650 0 $a Stem cells $x Therapeutic use. $3 1066248
650 1 4 $a Stem Cells. $3 580755
650 2 4 $a Regenerative Medicine/Tissue Engineering. $3 2055677
650 2 4 $a Ophthalmology. $3 862704
700 1 $a Zarbin, Marco A. $3 2152736
700 1 $a Singh, Mandeep S. $3 3385069
700 1 $a Casaroli-Marano, Ricardo P. $3 3385070
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Stem cell biology and regenerative medicine. $3 1566296
856 4 0 $u https://doi.org/10.1007/978-3-030-05222-5
950 $a Biomedical and Life Sciences (Springer-11642)